Anna L. Parks
( out of 41 reviews )

Anna L. Parks, MD

Languages spoken: English, Spanish

Clinical Locations

Sugar House Health Center

Salt Lake City
801-581-2000

  • Dr. Anna Parks is an Assistant Professor in the Division of Hematology & Hematologic Malignancies at the University of Utah and a faculty member of the Center on Aging. Her clinical practice includes the treatment of non-malignant hematologic disorders, with a particular interest in thrombotic disorders. She is committed to teaching the next generation of leaders in hematology. Dr. Parks also conducts research to improve the care of older adults with bleeding and thrombosis.

    Dr. Parks graduated from Yale University. She received her medical degree, trained in Internal Medicine, served as a Chief Resident, and completed Hematology fellowship at the University of California, San Francisco. She completed a two-year NIH-funded fellowship in Aging Research at the University of California, San Francisco and received a certificate in Clinical Research.

    Dr. Parks grew up in Salt Lake City and is thrilled to be back. Outside of work, she enjoys cooking, reading fiction and hiking with her dog, husband and children.

    Specialties

    Board Certification

    American Board of Internal Medicine (Internal Medicine)
    American Board of Internal Medicine (Sub: Hematology)

    Patient Rating

    5.0 /5
    ( out of 41 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety.
    Patients are de-identified for confidentiality and patient privacy.

    October 30, 2024
    SUGAR HOUSE HEALTH CENTER

    Dr. Anna Parks and her staff are wonderful to work with. I would recommend Dr. Parks if you are wanting a Hematologist who is very knowledgeable in her profession , cares very much about her patients and is a joy to have as my doctor.

    October 17, 2024
    SUGAR HOUSE HEALTH CENTER

    Dr Parks and her team are top notch! I could not be happier with the care I have received from her and her team.

    October 10, 2024
    SUGAR HOUSE HEALTH CENTER

    Dr. Parks was very thorough, attentive, caring and explained everything clearly.

    October 02, 2024
    SUGAR HOUSE HEALTH CENTER

    I feel like she was very interested that I should get the best care

    September 04, 2024
    SUGAR HOUSE HEALTH CENTER

    Very knowledgeable & thorough. Takes her time explaining everything to you & the reasoning for the plan of action.

    July 20, 2024
    SUGAR HOUSE HEALTH CENTER

    Very pleasant!!

    July 17, 2024
    SUGAR HOUSE HEALTH CENTER

    Anna Parks is awesome. She was informative and friendly and made sure I understood what was going on, what my options were and what to do moving forward.

    July 10, 2024
    SUGAR HOUSE HEALTH CENTER

    Dr. Parks is fantastic to work with as my Hematologist. I would gladly recommend her to others.

    June 06, 2024
    SUGAR HOUSE HEALTH CENTER

    Dr. Parks is one of the kindest physicians I have ever met.

    See More Patient Comments

  • Dr. Anna Parks is an Assistant Professor in the Division of Hematology & Hematologic Malignancies at the University of Utah and a faculty member of the Center on Aging. Her clinical practice includes the treatment of non-malignant hematologic disorders, with a particular interest in thrombotic disorders. She is committed to teaching the next generation of leaders in hematology. Dr. Parks also conducts research to improve the care of older adults with bleeding and thrombosis.

    Dr. Parks graduated from Yale University. She received her medical degree, trained in Internal Medicine, served as a Chief Resident, and completed Hematology fellowship at the University of California, San Francisco. She completed a two-year NIH-funded fellowship in Aging Research at the University of California, San Francisco and received a certificate in Clinical Research.

    Dr. Parks grew up in Salt Lake City and is thrilled to be back. Outside of work, she enjoys cooking, reading fiction and hiking with her dog, husband and children.

    Board Certification and Academic Information

    Academic Departments Internal Medicine -Primary
    Academic Divisions Hematology & Hematologic Malignancies
    Board Certification
    American Board of Internal Medicine (Internal Medicine)
    American Board of Internal Medicine (Sub: Hematology)

    Education history

    Fellowship T32 Aging Research - University of California, San Francisco Fellow
    Fellowship Hematology and Oncology - University of California, San Francisco Fellow
    Residency Internal Medicine - University of California, San Francisco Chief Resident
    Residency Internal Medicine - University of California, San Francisco Resident
    Professional Medical Medicine - University of California, San Francisco School of Medicine M.D.
    Undergraduate History of Science & Medicine - Yale University B.A.

    Selected Publications

    Journal Article

    1. Parks AL, Stevens SM (2023). NSAIDs and hormonal contraceptives are linked to VTE in women with no previous thrombotic disease. Ann Intern Med, 176(12), JC143. (Read full article)
    2. Parks AL, Stevens SM (2023). In intermediate- or high-risk PE, catheter-directed thrombolysis is linked to reduced mortality vs. systemic thrombolysis or anticoagulation. Ann Intern Med. (Read full article)
    3. Parks AL, Fazili M, Aston V, Porter TF, Branch DW, Woller SC, Snow GL, Stevens SM (2023). Excluding pregnancy-associated deep vein thrombosis with whole-leg ultrasound. Res Pract Thromb Haemost, 7(7), 102202. (Read full article)
    4. de Jong CMM, de Wit K, Black SA, Gwozdz AM, Masias C, Parks AL, Robert-Ebadi H, Talerico R, Woller SC, Klok FA (2023). Use of patient-reported outcome measures in patients with venous thromboembolism: communication from the ISTH SSC Subcommittee on Predictive and Diagnostic Variables in Thrombotic Disease. J Thromb Haemost. (Read full article)
    5. Litt HK, Parks AL, Velazquez AI (2023). Blood Clots, or Thrombosis, in Patients With Cancer. JAMA Oncol. (Read full article)
    6. Fang MC, Reynolds K, Tabada GH, Prasad PA, Sung SH, Parks AL, Garcia E, Portugal C, Fan D, Pai AP, Go AS (2023). Assessment of the Risk of Venous Thromboembolism in Nonhospitalized Patients With COVID-19. JAMA Netw Open, 6(3), e232338. (Read full article)
    7. Fang MC, Go AS, Prasad PA, Zhou HX, Parks AL, Fan D, Portugal C, Sung SH, Reynolds K (2022). Health-related quality of life associated with warfarin and direct oral anticoagulants in venous thromboembolism. Thromb Res, 216, 97-102. (Read full article)
    8. Parks AL, Incze MA (2022). What Can At-home Genetic Tests Tell Me About My Health? JAMA Intern Med, 182(6), 691. (Read full article)
    9. Parks AL, Auerbach AD, Schnipper JL, Bertram A, Jeon SY, Boyle B, Fang MC, Gadrey SM, Siddiqui ZK, Brotman DJ, Hospital Medicine Reengineering Network HOMERuN (2022). Venous thromboembolism (VTE) prevention and diagnosis in COVID-19: Practice patterns and outcomes at 33 hospitals. PLoS One, 17(5), e0266944. (Read full article)
    10. Parks AL, Jeon SY, Boscardin WJ, Steinman MA, Smith AK, Covinsky KE, Fang MC, Shah SJ (2022). Long-term functional outcomes and mortality after hospitalization for extracranial hemorrhage. J Hosp Med, 17(4), 235-242. (Read full article)
    11. Cohen AB, Parks AL, Whitson HE, Zieman S, Brown CJ, Boyd C, Covinsky KE, Steinman MA (2020). Succeeding in Aging Research During the Pandemic: Strategies for Fellows and Junior Faculty. J Am Geriatr Soc, 69(1), 8-11. (Read full article)
    12. Parks AL, Auerbach AD, Schnipper JL, Anstey JE, Sterken DG, Hecht TEH, Fang MC, Hospital Medicine Reengineering Network HOMERuN (2020). COVID-19 coagulopathy and thrombosis: Analysis of hospital protocols in response to the rapidly evolving pandemic. Thromb Res, 196, 355-358. (Read full article)
    13. Parks AL, Fang MC (2017). Scoring Systems for Estimating the Risk of Anticoagulant-Associated Bleeding. Semin Thromb Hemost, 43(5), 514-524. (Read full article)
    14. Stern RJ, Parks AL (2016). Teaching High-Value Care on Rounds: Modeling Moderation. JAMA Intern Med, 176(2), 262-3. (Read full article)
    15. Parks AL, McWhirter RM, Evason K, Kelley RK (2015). Cases of spontaneous tumor regression in hepatobiliary cancers: implications for immunotherapy? J Gastrointest Cancer, 46(2), 161-5. (Read full article)
    16. Hammoud AO, Wilde N, Gibson M, Parks A, Carrell DT, Meikle AW (2008). Male obesity and alteration in sperm parameters. Fertil Steril, 90(6), 2222-5. (Read full article)

    Review

    1. Parks AL, Frankel DS, Kim DH, Ko D, Kramer DB, Lydston M, Fang MC, Shah SJ (2024). Management of atrial fibrillation in older adults. [Review]. BMJ, 386, e076246. (Read full article)
    2. Parks AL, Stevens SM, Woller SC (2024). Anticoagulant therapy in renal insufficiency theme: Anticoagulation in complex situations. [Review]. Thromb Res, 241, 109097. (Read full article)
    3. Parks AL, Fang MC (2023). Periprocedural Anticoagulation. [Review]. Ann Intern Med, 176(4), ITC49-ITC64. (Read full article)
    4. Parks AL, Fang MC (2016). Anticoagulation in Older Adults with Multimorbidity. [Review]. Clin Geriatr Med, 32(2), 331-46. (Read full article)

    Book Chapter

    1. Parks AL, Stevens S (). Hereditary Thrombophilias :Pathophysiology, Interpretation and Indications for Testing. In Syed A. Abutalib, M.D, Sangeetha Annaswamy (Eds.), Hoffman Textbook of Hematology (8). Spinger Nature.
    2. Parks AL, Andreadis C, Damon L (2021). Blood Disorders . In Papadakis M, McPhee S, Rabow M. (Eds.), Current Medical Diagnosis and Treatment (60th). McGraw Hill.

    Commentary

    1. Redberg RF, Parks AL, Rubin JB (2021). Persistent Gender Pay Gaps in Medicine: What Is Good for the Goose Is Better for the Gander's Paycheck. JAMA Intern Med, 181(9), 1164. (Read full article)
    2. Parks AL, Covinsky KE (2021). Anticoagulation at the End of Life: Time for a Rational Framework. JAMA Intern Med, 181(8), 1123. (Read full article)
    3. Parks AL, Kohlwes RJ (2017). Refining Risk for Deep Vein Thrombosis in Hospitalized Patients. J Gen Intern Med, 33(1), 6. (Read full article)
    4. Parks AL, Redberg RF (2017). Dabigatran Compared With Rivaroxaban vs Warfarin-Reply. JAMA Intern Med, 177(5), 744. (Read full article)
    5. Parks AL, Redberg RF (2016). Women in Medicine and Patient Outcomes: Equal Rights for Better Work? JAMA Intern Med, 177(2), 161. (Read full article)
    6. Parks AL, OMalley PG (2017). Applying Academic Detailing and Process Change to Promote Choosing Wisely-Reply. JAMA Intern Med, 177(2), 283. (Read full article)
    7. Parks AL, Redberg RF (2016). Comparing Non-Vitamin K Oral Anticoagulants: Where We Are Now. JAMA Intern Med, 176(11), 1672. (Read full article)
    8. Parks AL, OMalley PG (2016). From Choosing Wisely to Practicing Value-More to the Story. JAMA Intern Med, 176(10), 1571-1572. (Read full article)
    9. Parks AL, Covinsky KE (2016). Anticoagulation in the Very Old. JAMA Intern Med, 176(8), 1184. (Read full article)

    Case Report

    1. Han HJ, Parks AL, Shah MP, Hsu G, Santhosh L (2021). An Elusive Seizure. Neurohospitalist, 12(1), 188-194. (Read full article)

    Editorial

    1. Litt HK, Parks AL, Velazquez AI (). Blood Clots, or Thrombosis, in Patients with Cancer.
    2. Parks AL (2024). A sobering reminder and call to action: Preventing inpatient deaths from pulmonary emboli with a wraparound strategy. J Hosp Med. (Read full article)
    3. Incze MA, Parks AL, Stern RJ (2022). Teaching a Deeper Understanding of the Medical Literature. J Gen Intern Med, 38(4), 1-2. (Read full article)

    Abstract

    1. Brondfield S, Mulvey CK, Parks AL, et al (2021). Got Stage Fright? A Fellow-Led Initiative to Improve Cancer Staging Documentation.  [Abstract]. Int J Cancer.
    2. Parks AL, Kambhampati S, Fakhri B, Andreadis C, Gray L, Wong SW, Shah N, Fang MC (2020). Incidence, management and outcomes of arterial and venous thrombosis after chimeric antigen receptor modified T cells for B cell lymphoma and multiple myeloma. [Abstract]. Leuk Lymphoma, 62(4), 1003-1006. (Read full article)
    3. Parks AL, Jeon SY, Boscardin WJ, Steinman MA, Smith AK, Fang MC, Shah SJ (2021). Long-term individual and population functional outcomes in older adults with atrial fibrillation. [Abstract]. J Am Geriatr Soc, 69, 1570-1578. (Read full article)

    Video/Film/CD/Web/Podcast

    1. Parks AL, Fang MC (2018). Web M&M: Isolated Clot, Real Error [Web]. Agency for Healthcare Research and Quality Patient Safety Network. Available: https://psnet.ahrq.gov/web-mm/isolated-clot-real-error.